First Republic Investment Management, Inc. Vascular Biogenics Ltd. Transaction History

First Republic Investment Management, Inc.

  • $34.7 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 07, 2019
SELL
$1.16 - $1.53 $168,200 - $221,850
-145,000 Closed
0 $0
Q1 2019

Apr 30, 2019
BUY
$0.94 - $1.75 $9,400 - $17,500
10,000 Added 7.41%
145,000 $220,000
Q4 2018

Feb 12, 2019
SELL
$0.6 - $1.72 $162,000 - $464,400
-270,000 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$1.55 - $2.17 $418,500 - $585,900
270,000 New
270,000 $438,000

Others Institutions Holding VBLT

# of Institutions
2
Shares Held
416K
Call Options Held
0
Put Options Held
0
View Full List

About Vascular Biogenics Ltd.

VBLT Quotes by TradingView
  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email